This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Warszawski Uniwersytet Medyczny. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Innovator Spotlight: Dorota Maciejko
Introduction: Dorota Maciejko is a prominent inventor based in Warsaw, Poland. She has made significant contributions to the field of pharmacology, particularly focusing on compounds that have the potential to address vascular disorders. With her inventive spirit and dedication, she has pioneered research that leads to new therapeutic options.
Latest Patents: Dorota holds a patent for a "Protoescigenin derivative, process of its preparation, use of said compound and pharmaceutical composition comprising that compound." This patent describes a unique compound derived from protoescigenin, which exhibits pharmacological properties. The invention encompasses the process of preparing this compound and its application as a medicament for treating vascular disorders, along with a related pharmaceutical composition.
Career Highlights: Dorota Maciejko works at the Medical University of Warsaw, where her research focuses on the development of innovative drug formulations. Her work is essential in bridging the gap between academic research and practical medical applications. The impact of her contributions can lead to advancements in treatment protocols for vascular conditions, enhancing patient care.
Collaborations: Throughout her career, Dorota has collaborated with talented colleagues, including Katarzyna Koziak and Krzysztof Bojakowski. This teamwork has been vital in fostering a collaborative environment that drives forward the research and development of new medicinal compounds.
Conclusion: Dorota Maciejko is an exemplary inventor whose work in pharmacology demonstrates the potential for innovation to improve healthcare. With her patent and ongoing collaboration with fellow researchers, she is sure to continue making strides in the field, contributing valuable solutions for vascular disorders and beyond.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile